GI Pop Quiz! IBD includes 4 short quizzes designed to educate and inform healthcare providers on patient risk stratification, therapeutic drug monitoring, and treatment strategies for optimizing disease remission. Each quiz will be a microlearning online module that includes:
- 1 case with multiple-choice and open-ended questions that assess learners’ current knowledge and practice of IBD management
- 5 to 10 minutes recording of case explanation from the experts
- Comparison of responses with other learners and in-activity discussion board
Sign in to access
After you sign in, please click the "Launch" button on the top of this page to access the course.
Product Features:
GI Pop Quiz! is a flipped education approach that challenges learners to critically think through an individual patient case and see how their decisions compare with those of subject matter experts.
Course Director:
Aline Charabaty, MD, AGAF
Johns Hopkins School of Medicine
Assistant Clinical Director of the Division of Gastroenterology
Director of the IBD Center at Johns Hopkins - Sibley Memorial Hospital
Faculty:
Raymond K. Cross, MD, AGAF
Professor of Medicine
Director, IBD Program
Co-Director, Digestive Health Center
University of Maryland Medical System
Adam C. Ehrlich, MD, MPH
Associate Professor of Medicine
Program Director, Gastroenterology Fellowship
Co-Medical Director, Temple Inflammatory Bowel Disease Program
Department of Medicine, Section of Gastroenterology
Lewis Katz School of Medicine at Temple University
Jason N. Schairer, MD
Gastroenterologist
Henry Ford Health System
Learning Objectives:
- Determine appropriate treatment strategies and drug monitoring protocols for IBD patients.
- Identify appropriate treatment strategies for high-risk patients.
- Understand the use and efficacy of new and emerging biologic treatments.
Accreditation Statement
The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: Feb. 28, 2023
Disclosures
Aline Charabaty, MD, AGAF
Consulting: AbbVie, Takeda, Pfizer, Janssen, BMS
Raymond K. Cross, MD, MS, AGAF
Consulting: AbbVie, Eli Lilly, LabCorp, Samsung bioepis
Advisory Committee/Review Panel: AbbVie, BMS, Janssen, Takeda, Pfizer
Adam C. Ehrlich, MD, MPH
Consulting: Level Ex
Advisory Committee/Review Panel: Pfizer, Bristol Meyers Scquibb
Jason N. Schairer, MD
No financial relationship with a commercial interest.